Big mover
Phase 2Data readoutOct 31, 2026
Details Market and catalyst intelligence
Find biotech companies with meaningful price action or catalyst-linked signals, then filter the research list by signal type or company.
Highest priority
Cullinan Management · Non-small cell lung carcinoma (NSCLC) with EGFR Exon 20 Insertion Mutations
Olema Pharmaceuticals · Metastatic breast cancer, Cancer
Zentalis Pharmaceuticals · Cyclin E1+ platinum-resistant ovarian cancer (PROC)
Additional signals
Updated Aug 23, 2026. Mover signals are research indicators, not investment advice.
Aclaris Therapeutics Inc. · Atopic dermatitis
Syndax Pharmaceuticals · Graft-versus-host disease
Pacira BioSciences · Osteoarthritis Shoulder Pain
Tectonic Therapeutic · Pulmonary hypertension in Heart failure with preserved Ejection Fraction (PH-HFpEF)
ARS Pharmaceuticals · Acute flares in patients with chronic spontaneous urticaria